OBJECTIVE: The effect of adolescent marijuana use on brain development remains unclear despite relaxing legal restrictions, decreased perceived harm, and increasing use rates among youth. The aim of this 3-year prospective study was to evaluate the long-term neurocognitive effects of adolescent marijuana use. METHOD: Adolescent marijuana users with concomitant alcohol use (MJ + ALC, n = 49) and control teens with limited substance use histories (CON, n = 59) were given neuropsychological and substance use assessments at project baseline, when they were ages 16-19. They were then reassessed 18 and 36 months later. Changes in neuropsychological measures were evaluated with repeated measures analysis of covariance (ANCOVA), controlling for lifetime alcohol use, and examined the effects of group, time, and group by time interactions on cognitive functioning. RESULTS: MJ + ALC users performed significantly worse than controls, across time points, in the domains of complex attention, memory, processing speed, and visuospatial functioning (ps <.05). Earlier age of marijuana use onset was associated with poorer processing speed and executive functioning by the 3-year follow-up (ps ≤.02). CONCLUSIONS: Frequent marijuana use throughout adolescence and into young adulthood appeared linked to worsened cognitive performance. Earlier age of onset appears to be associated with poorer neurocognitive outcomes that emerge by young adulthood, providing further support for the notion that the brain may be uniquely sensitive to frequent marijuana exposure during the adolescent phase of neurodevelopment. Continued follow-up of adolescent marijuana users will determine the extent of neural recovery that may occur if use abates. (c) 2015 APA, all rights reserved).
OBJECTIVE: The effect of adolescent marijuana use on brain development remains unclear despite relaxing legal restrictions, decreased perceived harm, and increasing use rates among youth. The aim of this 3-year prospective study was to evaluate the long-term neurocognitive effects of adolescent marijuana use. METHOD: Adolescent marijuana users with concomitant alcohol use (MJ + ALC, n = 49) and control teens with limited substance use histories (CON, n = 59) were given neuropsychological and substance use assessments at project baseline, when they were ages 16-19. They were then reassessed 18 and 36 months later. Changes in neuropsychological measures were evaluated with repeated measures analysis of covariance (ANCOVA), controlling for lifetime alcohol use, and examined the effects of group, time, and group by time interactions on cognitive functioning. RESULTS: MJ + ALC users performed significantly worse than controls, across time points, in the domains of complex attention, memory, processing speed, and visuospatial functioning (ps <.05). Earlier age of marijuana use onset was associated with poorer processing speed and executive functioning by the 3-year follow-up (ps ≤.02). CONCLUSIONS: Frequent marijuana use throughout adolescence and into young adulthood appeared linked to worsened cognitive performance. Earlier age of onset appears to be associated with poorer neurocognitive outcomes that emerge by young adulthood, providing further support for the notion that the brain may be uniquely sensitive to frequent marijuana exposure during the adolescent phase of neurodevelopment. Continued follow-up of adolescent marijuana users will determine the extent of neural recovery that may occur if use abates. (c) 2015 APA, all rights reserved).
Authors: Susan F Tapert; Alecia D Schweinsburg; Valerie C Barlett; Sandra A Brown; Lawrence R Frank; Gregory G Brown; M J Meloy Journal: Alcohol Clin Exp Res Date: 2004-10 Impact factor: 3.455
Authors: Alecia D Schweinsburg; Brian C Schweinsburg; Erick H Cheung; Gregory G Brown; Sandra A Brown; Susan F Tapert Journal: Drug Alcohol Depend Date: 2005-02-26 Impact factor: 4.492
Authors: Krista Lisdahl Medina; Tim McQueeny; Bonnie J Nagel; Karen L Hanson; Tony T Yang; Susan F Tapert Journal: Addict Biol Date: 2009-07-24 Impact factor: 4.280
Authors: Wendy M Bosker; Erin L Karschner; Dayong Lee; Robert S Goodwin; Jussi Hirvonen; Robert B Innis; Eef L Theunissen; Kim P C Kuypers; Marilyn A Huestis; Johannes G Ramaekers Journal: PLoS One Date: 2013-01-02 Impact factor: 3.240
Authors: Olivier J Barthelemy; Mark A Richardson; Timothy C Heeren; Clara A Chen; Jane M Liebschutz; Leah S Forman; Howard J Cabral; Deborah A Frank; Ruth Rose-Jacobs Journal: J Stud Alcohol Drugs Date: 2019-01 Impact factor: 2.582
Authors: Joanna Jacobus; Charles T Taylor; Kevin M Gray; Lindsay R Meredith; Anna M Porter; Irene Li; Norma Castro; Lindsay M Squeglia Journal: Drug Alcohol Depend Date: 2018-04-11 Impact factor: 4.492
Authors: Lindsay M Squeglia; Nathaniel L Baker; Erin A McClure; Rachel L Tomko; Vitria Adisetiyo; Kevin M Gray Journal: Addict Behav Date: 2016-08-04 Impact factor: 3.913
Authors: Jodi M Gilman; Randi M Schuster; Max T Curran; Vanessa Calderon; Andre van der Kouwe; A Eden Evins Journal: Cogn Affect Behav Neurosci Date: 2016-08 Impact factor: 3.282